QuiVad

Home / Netherlands / Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 5.00% on May 21, 2018. The shaded band matches the twelve months of the first chart.

July 31, 2015 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on Lakefront Biotherapeutics NV by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

689 disclosures on record for this share.
DateFund% of capitalEnd of publication
April 3, 2025Qube Research & Technologies Ltd.0.47%
March 28, 2025Citadel Advisors LLC0.50%
March 21, 2025Marshall Wace LLP0.59%
March 10, 2025Qube Research & Technologies Ltd.1.20%
March 3, 2025Arrowstreet Capital, Limited Partnership0.88%
February 24, 2025Arrowstreet Capital, Limited Partnership0.98%
February 21, 2025Connor, Clark & Lunn Investment Management Ltd.0.49%
February 20, 2025Arrowstreet Capital, Limited Partnership1.06%
February 20, 2025Marshall Wace LLP0.61%
February 17, 2025Marshall Wace LLP0.58%
February 13, 2025Qube Research & Technologies Ltd.1.12%
February 13, 2025Marshall Wace LLP0.63%
February 12, 2025Connor, Clark & Lunn Investment Management Ltd.0.50%
February 5, 2025WorldQuant, LLC0.48%
February 4, 2025Marshall Wace LLP0.50%
January 29, 2025WorldQuant, LLC0.51%
January 16, 2025Qube Research & Technologies Ltd.1.00%
January 13, 2025Qube Research & Technologies Ltd.0.90%
January 10, 2025Qube Research & Technologies Ltd.0.86%
January 7, 2025Arrowstreet Capital, Limited Partnership1.19%
December 30, 2024Qube Research & Technologies Ltd.0.71%
December 27, 2024Qube Research & Technologies Ltd.0.69%
December 19, 2024Arrowstreet Capital, Limited Partnership1.20%
December 19, 2024Qube Research & Technologies Ltd.0.71%
November 20, 2024Qube Research & Technologies Ltd.0.61%
November 15, 2024Qube Research & Technologies Ltd.0.51%
November 7, 2024Qube Research & Technologies Ltd.0.49%
November 4, 2024Qube Research & Technologies Ltd.0.50%
October 29, 2024Arrowstreet Capital, Limited Partnership1.19%
September 12, 2024Arrowstreet Capital, Limited Partnership1.27%
August 13, 2024Arrowstreet Capital, Limited Partnership1.39%
June 25, 2024Arrowstreet Capital, Limited Partnership1.49%
November 16, 2023Qube Research & Technologies Ltd.0.49%
November 15, 2023Qube Research & Technologies Ltd.0.50%
November 9, 2023Qube Research & Technologies Ltd.0.49%
November 7, 2023Qube Research & Technologies Ltd.0.51%
October 30, 2023Qube Research & Technologies Ltd.0.49%
September 18, 2023Qube Research & Technologies Ltd.0.50%
September 15, 2023Qube Research & Technologies Ltd.0.49%
September 6, 2023Qube Research & Technologies Ltd.0.51%
September 4, 2023Qube Research & Technologies Ltd.0.49%
September 1, 2023Qube Research & Technologies Ltd.0.50%
August 31, 2023Arrowstreet Capital, Limited Partnership1.56%
August 29, 2023Qube Research & Technologies Ltd.0.49%
August 24, 2023Qube Research & Technologies Ltd.0.50%
August 23, 2023Qube Research & Technologies Ltd.0.48%
August 7, 2023Qube Research & Technologies Ltd.0.51%
July 31, 2023Qube Research & Technologies Ltd.0.48%
July 7, 2023Qube Research & Technologies Ltd.0.59%
July 5, 2023AHL Partners LLP0.49%

Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the Netherlands

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=2